You just read:

NICE Recommends Translarna™ (ataluren) for the Treatment of Patients with Nonsense Mutation Duchenne Muscular Dystrophy in England

News provided by

PTC Therapeutics, Inc.

Apr 15, 2016, 11:16 ET